VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,721,998 | -9.8% | 63,991 | +1.0% | 0.38% | -8.4% |
Q2 2023 | $1,908,101 | -7.3% | 63,371 | -0.4% | 0.42% | -16.0% |
Q1 2023 | $2,058,625 | +12.8% | 63,636 | +0.0% | 0.50% | +10.2% |
Q4 2022 | $1,825,527 | +123.4% | 63,611 | +87.8% | 0.45% | +101.3% |
Q3 2022 | $817,000 | -17.0% | 33,873 | -5.7% | 0.22% | -9.0% |
Q2 2022 | $984,000 | -30.4% | 35,928 | -2.5% | 0.24% | -18.1% |
Q1 2022 | $1,413,000 | +20.1% | 36,834 | +0.2% | 0.30% | +8.3% |
Q4 2021 | $1,177,000 | -9.0% | 36,749 | -16.3% | 0.28% | -16.9% |
Q3 2021 | $1,294,000 | -15.3% | 43,894 | -2.3% | 0.33% | -11.5% |
Q2 2021 | $1,527,000 | -7.7% | 44,943 | -11.8% | 0.38% | -18.5% |
Q1 2021 | $1,655,000 | -10.4% | 50,935 | -0.6% | 0.46% | -17.4% |
Q4 2020 | $1,847,000 | -10.8% | 51,265 | -3.1% | 0.56% | -22.4% |
Q3 2020 | $2,071,000 | -1.5% | 52,895 | -7.7% | 0.72% | -12.4% |
Q2 2020 | $2,102,000 | +52.0% | 57,317 | -4.5% | 0.82% | +30.0% |
Q1 2020 | $1,383,000 | – | 60,044 | – | 0.63% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Memorial Sloan Kettering Cancer Center | 738,500 | $19,873,035 | 80.92% |
New Harbor Financial Group, LLC | 1,680,752 | $45,229,033 | 14.96% |
TORQ CAPITAL MANAGEMENT (HK) Ltd | 139,000 | $3,740,490 | 9.95% |
Vanderbilt University | 1,360,540 | $36,612,131 | 9.45% |
Eschler Asset Management LLP | 300,000 | $8,073,000 | 9.42% |
New Harbor Financial Group, LLC | 1,027,300 | $27,644,643 | 9.15% |
Guild Investment Management, Inc. | 139,333 | $3,749,454 | 6.28% |
Monaco Asset Management SAM | 750,000 | $20,182,500 | 5.98% |
STRATEGIC INVESTMENT MANAGEMENT, LLC | 132,460 | $3,867,832 | 4.74% |
PCG Wealth Advisors, LLC | 264,614 | $7,120,782 | 4.67% |